National Kidney Registry Ready to Support New OPTN Seven-Day Testing Requirements
"NKR places the highest priority on patient safety and the speed of patients receiving their needed kidney, and we've been coordinating thousands of expedited serology tests across 100+ hospitals for years," said National Kidney Registry CEO
The NKR's current turnaround time for serology testing is approximately two days, enabling transplant centers to meet the tighter testing window without putting scheduled surgeries at risk. To ensure a seamless transition for Member Centers, the NKR will begin operating under the new seven-day process on
The NKR has already started receiving requests from Member Centers to utilize the NKR's serology testing services for non-NKR direct donation transplants, which NKR has been providing for years. The ability to provide fast turnaround serology testing for NKR facilitated transplants and non-NKR transplants provides a single platform solution for these critical tests.
Centers seeking assistance with meeting the new seven-day testing timeline are encouraged to contact the NKR for additional information.
About the National Kidney Registry
The National Kidney Registry (www.kidneyregistry.com) is an organization whose mission is to save and improve the lives of people facing kidney failure by increasing the quality, speed, and number of living donor transplants while protecting all living donors.
Approximately thirty percent (30%) of all living donor kidney transplants performed annually in the United States are facilitated through the National Kidney Registry.
View original content to download multimedia:https://www.prnewswire.com/news-releases/national-kidney-registry-ready-to-support-new-optn-seven-day-testing-requirements-302833572.html
SOURCE National Kidney Registry
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICAC Commissioner concludes ASEAN anti-corruption meeting in Malaysia to spearhead regional graft-fighting alliance
- XTI Aerospace Announces Executive Leadership Transition
- NEW RESEARCH IDENTIFIES FIRST BLOOD BIOMARKER PANEL FOR DUPUYTREN DISEASE: A KEY STEP TOWARD A BLOOD TEST FOR A CONDITION THAT THREATENS THE HANDS OF 10 MILLION AMERICANS
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share